Related Experiment Videos
[Blood coagulation disorders in oncological patients]
1Abteilung Hämatologie, Hämostaseologie und Onkologie, Medizinische Hochschule Hannover. mvdepka@arcor.de
Der Internist
|January 13, 2005
Summary
Cancer patients frequently develop coagulation disorders like bleeding or blood clots, complicating diagnosis and treatment. This review covers common issues such as tumor-associated thrombophilia, acquired von Willebrand
Area of Science:
- Hematology
- Oncology
- Coagulation Disorders
Context:
- Malignancy-associated coagulopathies are common and complex.
- These disorders significantly impact patient morbidity and mortality.
- Accurate diagnosis and management are challenging clinical problems.
Purpose:
- To review common coagulation complications in cancer patients.
- To highlight key conditions including tumor-associated thrombophilia, acquired von Willebrand's disease, and thrombocytopenia.
- To discuss diagnostic and therapeutic challenges.
Summary:
- Patients with malignancies frequently experience acute coagulation disorders.
- Manifestations include thromboembolism, disseminated intravascular coagulation, or bleeding.
- Specific complications discussed are tumor-associated thrombophilia, acquired von Willebrand's disease, and thrombocytopenia.
Impact:
- Improved understanding of coagulation disorders in cancer.
- Potential for enhanced diagnostic strategies.
- Guidance for optimizing treatment in complex cases.